Short-Interval, Low-Dose Peptide Receptor Radionuclide Therapy in Combination with PD-1 Checkpoint Immunotherapy Induces Remission in Immunocompromised Patients with Metastatic Merkel Cell Carcinoma

Merkel cell carcinoma (MCC) is a neuroendocrine skin cancer of the elderly, with high metastatic potential and poor prognosis. In particular, the primary resistance to immune checkpoint inhibitors (ICI) in metastatic (m)MCC patients represents a challenge not yet met by any efficient treatment modal...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Alexandra Aicher, Anca Sindrilaru, Diana Crisan, Wolfgang Thaiss, Jochen Steinacker, Meinrad Beer, Thomas Wiegel, Karin Scharffetter-Kochanek, Ambros J. Beer, Vikas Prasad
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	MDPI AG 2022-07-01
Schriftenreihe:	Pharmaceutics
Schlagworte:	radiotherapy immunotherapy checkpoint inhibitors anti-PD-1 neuroendocrine tumors
Online-Zugang:	https://www.mdpi.com/1999-4923/14/7/1466
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!